Pharma news news from FierceBiotech
NewsTroubled Pfizer blueprints biotech venture effort
Up to now, Pfizer's use of investment funds has followed a few narrow channels: Diagnostics, software and drug technology outfits that promised to help in their drug commercialization efforts. But... Read more...
J&J makes big cuts at Alza and Scios
Two Bay area biotechs, Alza and Scios, are in line for some big layoffs as Johnson & Johnson slims down its pharma... Read more...
Lilly developing biotech drugs the old-fashioned way
Pharma's biotech strategy is pretty clear: Buy companies or license in drugs and technology to get a leg up in the... Read more...
J&J restructures pharma unit, laying off workers
Johnson & Johnson is taking the axe to its pharma division as it chops away at up to $750 million in costs. The company says it will continue to invest in new technologies, but faces some... Read more...
| Press ReleasesPRESS RELEASE: IMS Health Predicts 5 to 6 Percent Growth for Global Pharmaceutical Market in 2008 IMS Health Predicts 5 to 6 Percent Growth for Global Pharmaceutical Market in 2008, According to Annual Forecast Key Dynamics Shaping Market: • Drug treatment costs decline in major therapy areas Read more >> |
Get more Pharma news coverage at:
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets
